Advertisement

Neurocritical Care

, Volume 29, Issue 3, pp 526–527 | Cite as

Response Letter: Neurological Disease Triggering Takotsubo Syndrome

  • Nicholas A. Morris
  • Santosh B. Murthy
  • Hooman Kamel
Letter to the Editor
  • 58 Downloads

Notes

Funding

Funding was provided by National Institute of Neurological Disorders and Stroke (Grant No. K23NS082367).

References

  1. 1.
    Overview of the National (Nationwide) Inpatient Sample (NIS). https://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed 24 Aug 2018.
  2. 2.
    Oppenheimer B, Fisberg A. Hypertensive encephalopathy. Arch Intern Med. 1928;41:264–78.CrossRefGoogle Scholar
  3. 3.
    Chester EM, Agamanolis DP, Banker BQ, Victor M. Hypertensive encephalopathy: a clinicopathologic study of 20 cases. Neurology. 1978;28:928–39.CrossRefPubMedGoogle Scholar
  4. 4.
    Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14:914–25.CrossRefPubMedGoogle Scholar
  5. 5.
    Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373:929–38.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society 2018

Authors and Affiliations

  • Nicholas A. Morris
    • 1
  • Santosh B. Murthy
    • 2
    • 3
  • Hooman Kamel
    • 2
    • 3
  1. 1.Program in Trauma, Department of NeurologyUniversity of Maryland School of MedicineBaltimoreUSA
  2. 2.Clinical and Translational Neuroscience UnitFeil Family Brain and Mind Research InstituteNew YorkUSA
  3. 3.Department of NeurologyWeill Cornell MedicineNew YorkUSA

Personalised recommendations